JP6122548B2 - 高血圧及び/又は線維症の処置用組成物 - Google Patents

高血圧及び/又は線維症の処置用組成物 Download PDF

Info

Publication number
JP6122548B2
JP6122548B2 JP2016515425A JP2016515425A JP6122548B2 JP 6122548 B2 JP6122548 B2 JP 6122548B2 JP 2016515425 A JP2016515425 A JP 2016515425A JP 2016515425 A JP2016515425 A JP 2016515425A JP 6122548 B2 JP6122548 B2 JP 6122548B2
Authority
JP
Japan
Prior art keywords
fibrosis
compound
pharmaceutically acceptable
hypertension
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016515425A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016532632A5 (enExample
JP2016532632A (ja
Inventor
アネット ダガン,カレン
アネット ダガン,カレン
Original Assignee
ヴェクタス バイオシステムズ リミテッド
ヴェクタス バイオシステムズ リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013903573A external-priority patent/AU2013903573A0/en
Application filed by ヴェクタス バイオシステムズ リミテッド, ヴェクタス バイオシステムズ リミテッド filed Critical ヴェクタス バイオシステムズ リミテッド
Publication of JP2016532632A publication Critical patent/JP2016532632A/ja
Publication of JP2016532632A5 publication Critical patent/JP2016532632A5/ja
Application granted granted Critical
Publication of JP6122548B2 publication Critical patent/JP6122548B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/32Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C235/34Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton containing six-membered aromatic rings having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP2016515425A 2013-09-17 2014-09-17 高血圧及び/又は線維症の処置用組成物 Active JP6122548B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013903573A AU2013903573A0 (en) 2013-09-17 Compositions for the treatment of hypertension and/or fibrosis
AU2013903573 2013-09-17
PCT/AU2014/000923 WO2015039173A1 (en) 2013-09-17 2014-09-17 Compositions for the treatment of hypertension and/or fibrosis

Publications (3)

Publication Number Publication Date
JP2016532632A JP2016532632A (ja) 2016-10-20
JP2016532632A5 JP2016532632A5 (enExample) 2016-12-08
JP6122548B2 true JP6122548B2 (ja) 2017-04-26

Family

ID=52687998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016515425A Active JP6122548B2 (ja) 2013-09-17 2014-09-17 高血圧及び/又は線維症の処置用組成物

Country Status (22)

Country Link
US (1) US9458093B2 (enExample)
EP (1) EP3046901B1 (enExample)
JP (1) JP6122548B2 (enExample)
KR (1) KR101736416B1 (enExample)
CN (1) CN105683152B (enExample)
AP (1) AP2016009079A0 (enExample)
AU (1) AU2014324078B2 (enExample)
BR (1) BR112016005601B1 (enExample)
CA (1) CA2924356C (enExample)
DK (1) DK3046901T3 (enExample)
ES (1) ES2655455T3 (enExample)
IL (1) IL244621A (enExample)
MX (1) MX368865B (enExample)
MY (1) MY172557A (enExample)
NO (1) NO3046901T3 (enExample)
NZ (1) NZ717927A (enExample)
PH (1) PH12016500497B1 (enExample)
PL (1) PL3046901T3 (enExample)
RU (1) RU2635564C2 (enExample)
SG (1) SG11201601642WA (enExample)
UA (1) UA118111C2 (enExample)
WO (1) WO2015039173A1 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3284981B2 (ja) 1998-11-02 2002-05-27 株式会社デンソー 車両用交流発電機およびそのステータの製造方法

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9956166B2 (en) 2013-09-18 2018-05-01 Sorrento Therapeutics, Inc. Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
EP3271320B1 (en) * 2015-03-18 2019-10-23 Vectus Biosystems Limited Compositions for the treatment of fibrosis and fibrosis-related conditions
SG11201707555RA (en) 2015-03-18 2017-10-30 Vectus Biosystems Ltd Compositions for the treatment of kidney and/or liver disease
NZ741263A (en) * 2015-09-22 2022-07-01 Vectus Biosystems Ltd Synthesis of terphenyl compounds
AU2017248665B2 (en) * 2016-04-13 2023-01-05 Board Of Regents Of The University Of Nebraska Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin
IL264392B2 (en) * 2016-07-28 2024-08-01 Vectus Biosystems Ltd Substituted 1,4-phenyl -2-propanamide and compositions comprising them for the treatment of pulmonary fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2694288B1 (fr) * 1992-06-30 1994-09-09 Rhone Poulenc Agrochimie Phenylbenzamides fongicides et procédés pour les préparer.
KR101638308B1 (ko) * 2004-06-11 2016-07-08 벡투스 바이오시스템즈 리미티드 심혈관 질환의 치료를 위한 조성물 및 방법
KR101404561B1 (ko) * 2005-12-09 2014-06-11 벡투스 바이오시스템즈 피티와이 리미티드 Vip 단편 및 사용 방법
US20120088737A2 (en) 2009-10-02 2012-04-12 Ajinomoto Co., Inc Novel acyl guanidine derivatives
UA117254C2 (uk) * 2013-09-17 2018-07-10 Вектус Байосистемз Лімітед Композиція (варіанти) для лікування гіпертензії та/або фіброзу

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3284981B2 (ja) 1998-11-02 2002-05-27 株式会社デンソー 車両用交流発電機およびそのステータの製造方法

Also Published As

Publication number Publication date
CN105683152A (zh) 2016-06-15
IL244621A (en) 2017-04-30
UA118111C2 (uk) 2018-11-26
MY172557A (en) 2019-12-02
CN105683152B (zh) 2017-03-22
IL244621A0 (en) 2016-04-21
EP3046901B1 (en) 2017-10-18
AU2014324078B2 (en) 2016-12-15
CA2924356C (en) 2018-04-03
MX2016003371A (es) 2016-10-21
RU2635564C2 (ru) 2017-11-14
NZ717927A (en) 2018-12-21
KR101736416B1 (ko) 2017-05-16
ES2655455T3 (es) 2018-02-20
PH12016500497A1 (en) 2016-06-13
BR112016005601A8 (pt) 2020-02-18
AU2014324078A1 (en) 2016-04-07
BR112016005601B1 (pt) 2021-02-02
PH12016500497B1 (en) 2017-12-13
PL3046901T3 (pl) 2018-03-30
CA2924356A1 (en) 2015-03-26
DK3046901T3 (en) 2018-01-02
KR20160074471A (ko) 2016-06-28
MX368865B (es) 2019-08-02
NO3046901T3 (enExample) 2018-03-17
EP3046901A4 (en) 2017-04-12
RU2016112257A (ru) 2017-10-20
AP2016009079A0 (en) 2016-03-31
US20160221933A1 (en) 2016-08-04
WO2015039173A1 (en) 2015-03-26
SG11201601642WA (en) 2016-04-28
JP2016532632A (ja) 2016-10-20
EP3046901A1 (en) 2016-07-27
US9458093B2 (en) 2016-10-04

Similar Documents

Publication Publication Date Title
JP6122548B2 (ja) 高血圧及び/又は線維症の処置用組成物
JP2000509395A (ja) 無機イオン活性化合物
CN101965184A (zh) 合成三萜类化合物及用以治病之方法
JPWO2008139879A1 (ja) G蛋白質共役型レセプター抑制剤および医薬
TWI848911B (zh) 以三唑并吡啶治療rbp4相關疾病之方法
JP6293266B2 (ja) 高血圧及び/又は線維症の処置用組成物
US20100184860A1 (en) Novel Carboxylic Acid and Antidepressant Composition Containing the Same as Active Ingredient
CN101715437A (zh) 立体异构异丙酚治疗性化合物
TW201544108A (zh) 異喹啉生物鹼衍生物用於製備促進ampk活性的藥物之用途
US20210346331A1 (en) Trpv4 activity inhibitor
WO2025137568A1 (en) Modulators of thr-beta and methods of use thereof
US10183908B2 (en) Compositions for the treatment of kidney and/or liver disease
JP2008506722A (ja) シス−1,2−置換スチルベン誘導体、および糖尿病の治療および/または予防のための薬剤の製造におけるそれらの使用
HK1226324A1 (en) Compositions for the treatment of hypertension and/or fibrosis
HK1226324B (en) Compositions for the treatment of hypertension and/or fibrosis
JPWO2014030624A1 (ja) スチルベン誘導体を有効成分として含有する筋緊張性ジストロフィー治療剤
TR2021022296A2 (tr) Ti̇p 2 diabetes mellitus hastaliğinin tedavi̇si̇ i̇çi̇n bi̇r i̇laç ve bu i̇lacin nanoparti̇külü
HK1148196B (en) Use of synthetic triterpenoids in the manufacture of medicament

Legal Events

Date Code Title Description
RD01 Notification of change of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7426

Effective date: 20160823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20160823

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20161017

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20161017

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20161017

A975 Report on accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A971005

Effective date: 20170208

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20170216

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20170221

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170314

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170331

R150 Certificate of patent or registration of utility model

Ref document number: 6122548

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250